Clinical Trials Directory

Trials / Completed

CompletedNCT01766843

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Orion Corporation, Orion Pharma · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the test product Salmeterol/fluticasone Easyhaler with the reference product Seretide Diskus in terms of drug absorbed in the bloodstream.

Conditions

Interventions

TypeNameDescription
DRUGSeretide Diskus and charcoal2 inhalations as a single dose
DRUGSeretide Diskus2 inhalations as a single dose
DRUGSF Easyhaler and charcoal2 inhalations as a single dose
DRUGSF Easyhaler2 inhalations as a single dose

Timeline

Start date
2013-01-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2013-01-11
Last updated
2014-01-03

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01766843. Inclusion in this directory is not an endorsement.